Vanadate induces necrotic death in neonatal rat cardiomyocytes through mitochondrial membrane depolarization

Chemical Research in Toxicology

Volumn 21, Issue 3, 2008, Pages 607-618

  Soares, Sandra Sofia ^a   Henao, Fernando ^b   Aureliano, Manuel ^a   Gutiérrez Merino, Carlos ^b  

^a UNIVERSITY OF ALGARVE   (Portugal)

^b UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CASPASE 3; DECAVANADIC ACID; HYDROETHIDINE; OLIGOMER; SUPEROXIDE; UNCLASSIFIED DRUG; VANADIUM; VANADIUM DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CALCIUM CELL LEVEL; CELL DEATH; CELL MEMBRANE DEPOLARIZATION; CELL VIABILITY; CONTROLLED STUDY; HEART MUSCLE CELL; MITOCHONDRIAL MEMBRANE; NEWBORN; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; RAT; TOXICOKINETICS;

ANIMALS; ANIMALS, NEWBORN; BENZIMIDAZOLES; CALCIUM; CARBOCYANINES; CASPASE 3; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CHEMISTRY, PHYSICAL; ENERGY TRANSFER; FLUORESCENT DYES; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; MYOCYTES, CARDIAC; NECROSIS; OXIDATION-REDUCTION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; VANADATES;

RATTUS; TETRA;

EID: 41849134685     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700204r     Document Type: Article

References (84)

1. Conde, A. G., Lau, S. S., Dillmann, W. H., and Mestril, R. (1997) Induction of heat shock proteins by tyrosine kinase inhibitors in rat cardiomyocytes and myogenic cells confers protection against simulated ischemia. J. Mol. Cell Cardiol. 29, 1927-1938.
2. Mackay, K., and Mochly-Rosen, D. (2000) Involvement of a p38 mitogen-activated protein kinase phosphatase in protecting neonatal rat cardiac myocytes from ischemia. J. Mol. Cell Cardiol. 32, 1585-1588.
3. Takada, Y., Hashimoto, M., Kasahara, J., Aihara, K., and Fukunaga, K. (2004) Cytoprotective effect of sodium orthovanadate on ischaemia/reperfusion - induced injury in the rat heart involves AkT activation and inhibition of fodrin breakdown and apoptosis. J. Pharmacol. Exp. Ther. 311, 1249-1255.
4. Josephson, L., and Cantley, L. C. (1977) Isolation of a potent (Na-K)ATPase inhibitor from striated muscle. Biochemistry 16, 4572-4578.
5. Barbagallo, M., Dominguez, L. J., and Resnick, L. M. (2001) Insulin-mimetic action of vanadate: Role of intracellular magnesium. Hypertension 38, 701-704.
6. Fawcett, J. P., Farquhar, S. J., Walker, R. J., Thou, T., Lowe, G., and Goulding, A. (1996) The effect of oral vanadyl sulphate on body composition and performance in weight-training athletes. Int. J. Sport Nutr. 6, 382-390.
7. Gerrard, D. F., Fawcett, J. P., and Farquhar, S. J. (1993) Vanadium use by athletes. N. Z. Med. J. 106, 259.
8. Fawcett, J. P., Farquhar, S. J., Thou, T., and Shand, B. I. (1997) Oral vanadyl sulphate does not affect blood cells, viscosity or biochemistry in humans. Pharmacol. Toxicol. 80, 202-206.
9. Yin, X., Davidson, A. J., and Tsang, S. S. (1992) Vanadate-induced gene expression in mouse C127 cells: Roles of oxygen derived active species. Mol. Cell. Biochem. 115, 85-96.
10. Stern, A., Yin, X., Tsang, S. S., Davidson, A., and Moon, J. (1993) Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem. Cell Biol. 71, 103-112.
11. Bay, B. H., Sit, K. H., Paramanantham, R., and Chan, Y. G. (1997) Hydroxyl free radicals generated by vanadyl [IV] induce cell blebbing in mitotic human Chang liver cells. Biometals 10, 119-122.
12. Ye, J.-P., Ding, M., Leonard, S. S., Robinson, V. A., Millecchia, L., Zhang, X., Castranova, V., Vallyathan, V., and Shi, X. (1999) Vanadate induces apoptosis in epidermal JB6 Pplus cells via hydrogen peroxide-mediated reactions. Mol. Cell. Biochem. 202, 9-17.
13. Capella, L. S., Alcantara, J. S. M., Moura-Neto, V., Lopes, A. G., and Capella, M. A. M. (2000) Vanadate is toxic to adherent-growing multidrug-resistant cells. Tumour Biol. 21, 54-62.
14. Capella, L. S., Gefé, M. A., Silva, E. F., Affonso-Mitidieri, O., Lopes, A. G., Rumjanek, V. M., and Capella, M. A. M. (2002) Mechanisms of vanadate-induced cellular toxicity: role of cellular glutathione and NADPH. Arch. Biochem. Biophys. 406, 65-72.
15. Etcheverry, S. B., and Cortizo, A. N. (1998) Bioactivity of vanadium compounds on cells in culture. In Vanadium in the Environment, Part 1: Chemistry and Biochemistry (Nriagu, J. O., Ed.) pp 359-395, John Wiley & Sons, Inc., New York.
16. Trudel, S., Pâquet, M. R., and Grinstein, S. (1991) Mechanism of vanadate-induced activation of tyrosine phosphorylation and of the respiratory burst in HL60 cells. Role of reduced oxygen metabolites. Biochem. J. 276, 611-619.
17. Volberg, T., Zick, Y., Dror, R., Sabanay, I., Gilon, C., Levitzki, A., and Geiger, B. (1992) The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions. EMBO J. 11, 1733-1742.
18. Secrist, J. P., Burns, L. A., Karnitz, L., Koretzky, G. A., and Abraham, R. T. (1993) Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem. 268, 5886-5893.
19. Harland, B. F., and Harden-Williams, B. A. (1994) Is vanadium of human nutritional importance yet? J. Am. Diet. Assoc. 94, 891-894.
20. Barceloux, D. G. (1999) Vanadium. Clin. Toxicol. 37, 265-278.
21. Thompson, K. H., Battell, M., and McNeill, J. H. (1998) Toxicology of vanadium in mammals. In Vanadium in the Environment, Part 2: Health Effects (Nriagu, J. O., Ed.) pp 21-37, John Wiley & Sons, Inc., New York.
22. Anke, M., Illing-Günther, H., Güntler, H., Holzinger, S., Jaritz, M., Anke, S., and Schäfer, U. (2000) Vanadium - An essencial element for animals and humans? In Trace Elements in Man and Animals (Roussel, A. M., Anderson, R. A., and Favrier, A. E., Eds.) pp 221-225, Kluwer Academic/Plenum Publishers, New York.
23. Rehder, D. (1995) Inorganic considerations on the function of vanadium in biological systems. Met. Ions Biol. Syst. 31, 1-43.
24. Sabbioni, E., Pozzi, G., Pintar, A., Casella, L., and Garattini, S. (1991) Cellular retention, cytotoxicity and morphological transformation by vanadium(IV) and vanadium(V) in BALB/3T3 cell lines. Carcinogenesis 12, 47-52.
25. Sabbioni, E., Pozzi, G., Devos, S., Pintar, A., Casella, L., and Fischbach, M. (1993) The intensity of vanadium(V)-induced cytotoxicity and morphological transformation in BALB/3T3 cells is dependent on glutathione-mediated bioreduction to vanadium(IV). Carcinogenesis 14, 2565-2568.
26. Willsky, G. R., and Dosch, S. F. (1986) Vanadium metabolism in wild type and respiratory-deficient strains of S. cerevisiae. Yeast 2, 77-85.
27. Aureliano, M., Joaquim, N., Sousa, A., Martins, H., and Coucelo, J. M. (2002) Oxidative stress in toadfish (Halobatrachus didactylus) cardiac muscle: Acute exposure to vanadate oligomers. J. Inorg. Biochem. 90, 159-165.
28. Aureliano, M., and Gândara, R. M. C. (2005) Decavanadate effects in biological systems. J. Inorg. Biochem. 99, 979-985.
29. Soares, S. S., Martins, H., and Aureliano, M. (2006) Vanadium distribution following decavanadate administration. Arch. Environ. Contam. Toxicol. 50, 60-64.
30. Soares, S. S., Martins, H., Duarte, R. O., Moura, J. J. G., Coucelo, J., Gutiérrez-Merino, C., and Aureliano, M. (2007) Vanadium distribution, lipid peroxidation and oxidative stress markers upon decavanadate in vivo administration. J. Inorg. Biochem. 101, 80-88.
31. Tiago, T., Aureliano, M., and Gutiérrez-Merino, C. (2004) Decavanadate binding to a high affinity site near the catalytic centre inhibits F-Actin-stimulated myosin ATPase activity. Biochemistry 43, 5551-5561.
32. Aureliano, M., Soares, S. S., Tiago, T., Ramos, S., and Gutiérrez-Merino, C. (2007) Biological effects of decavanadate: Muscle contraction, in vivo oxidative stress, and mitochondrial toxicity. In Vanadium: The Versatile Metal (Kustin, K., Pessoa, J. C., and Crans, D. C., Eds.) pp 249-263, ACS Symposium Series, American Chemical Society, Washington, DC.
33. Ramos, S., Manuel, M., Tiago, T., Gândara, R. M. C., Duarte, R. O., Moura, J. J. G., Gutiérrez-Merino, C., and Aureliano, M. (2006) Decavanadate interactions with actin: Inhibition of G-actin polymerization and stabilization of decameric vanadate. J. Inorg. Biochem. 99, 1734-1743.
34. Borges, G., Mendonça, P., Joaquim, N., Aureliano, M., and Coucelo, J. M. (2003) Acute effects of vanadate oligomers on heart, kidney, and liver histology in the Lusitanian toadfish (Halobatrachus didactylus). Arch. Environ. Contam. Toxicol. 45, 415-422.
35. Soares, S. S., Aureliano, M., Joaquim, N., and Coucelo, J. M. (2003) Cadmium and vanadate oligomers effects on methaemoglobin reductase activity from Lusitanian toadfish: In vivo and in vitro studies. J. Inorg. Biochem. 94, 285-289.
36. Gândara, R. M. C., Soares, S. S., Martins, H., Gutiérrez- Merino, C., and Aureliano, M. (2005) Vanadate oligomers: In vivo effects in hepatic vanadium accumulation and stress markers. J. Inorg. Biochem. 99, 1238-1244.
37. Soares, S. S., Gutiérrez-Merino, C., and Aureliano, M. (2007) Decavanadate induces mitochondrial membrane depolarization and inhibits oxygen consumption. J. Inorg. Biochem. 101, 789-796.
38. Nechay, B. R. (1984) Mechanisms of action of vanadium. Annu. Rev. Pharmacol. Toxicol. 24, 501-524.
39. Stankiewicz, P. J., Tracey, A. S., and Crans, D. C. (1995) Inhibition of phosphate-metabolizing enzymes by oxovanadium (V) complexes. In Metal Ions in Biological Systems: Vanadium and Its Role in Life (Sigel H., and Sigel, A., Eds.) pp 287-324, Marcel Dekker, New York.
40. Gresser, M. J., and Tracey, A. S. (1990) Vanadates as phosphate analogs in biochemistry. In Vanadium in Biological System (Chasteen, N. D., Ed.) pp 63-79, Kluwer Academic Publishers, The Netherlands.
41. Cortizo, A. M., Salice, V. C., and Etcheverry, S. B. (1994) Vanadium compounds. Their action on alkaline phosphate activity. Biol. Trace Elem. Res. 41, 331-339.
42. Crans, D. C. (1994) Aqueous chemistry of labile oxovanadate: relevance to biological studies. Comments Inorg. Chem. 16, 1-33.
43. Chlopcikova, S., Psotova, J., and Miketova, P. (2001) Neonatal rat cardiomyocytes - A model for the study of morphological, biochemical and electrophysiological characteristics of the heart. Biomed. Pap. 145, 49-55.
44. Martín-Romero, F. J., Santiago-Josefat, B., Correa-Bordes, J., Gutiérrez-Merino, C., and Fernandez-Salguero, P. (2000) Potassium-induced apoptosis in rat cerebellar granule cells involves cell-cycle blockade at the G1/S transition. J. Mol. Neurosci. 15, 155-165.
45. Samhan-Arias, A. K., Martín-Romero, F. J., and Gutiérrez-Merino, C. (2004) Kaempferol blocks oxidative stress in cerebellar granule cells and reveals a key role for reactive oxygen species production at the plasma membrane in the commitment to apoptosis. Free Radical Biol. Med. 37, 48-71.
46. Abu-Shakra, S., Alhalabi, M. S., Nachtman, F. C., Schemidt, R. A., and Brusilow, W. S. (1997) Anabolic steroids induce injury and apoptosis of differentiated skeletal muscle. J. Neurosci. Res. 47, 186-197.
47. Estabrook, R. W., Williamson, J. R., Frenkel, R., and Maitra, P. K. (1967) The fluorometric determination of mitochondrial adenine and pyridine nucleotides. Methods Enzymol. 10, 474-482.
48. 2+. J. Biol. Chem. 274, 1667-1676.
49. + gradient and by extrasynaptosomal ATP. J. Neurochem. 65, 2757-2764.
50. Thomas, A. P., and Delaville, F. (1991) The use of fluorescent indicators for measurements of cytosol-free calcium concentration in cell populations and single cells. In Cellular Calcium: A Practical Approach (McCormack, J. G., and Cobbold, P. H., Eds.) pp 1-54, Oxford University Press, Oxford.
51. Greenlund, L. J., and Deckwerth, T. L., Jr. (1995) Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron 14, 303-315.
52. Keller, A., Mohamed, A., Drose, S., Brandt, U., Fleming, I., and Brandes, R. P. (2004) Analysis of dichlorodihydrofluorescein and dihydrocalcein as probes for the detection of intracellular reactive oxygen species. Free Radical Res. 38, 1257-1267.
53. Budd, S. L., Castilho, R. F., and Nicholls, D. G. (1997) Mitochondrial membrane potential and hydroethidine-monitored superoxide generation in cultured cerebellar granule cells. FEBS Lett. 415, 21-24.
54. Mathur, A., Hong, Y., Kemp, B. K., Barrientos, A. A., and Erusalimsky, J. D. (2000) Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc. Res. 46, 126-138.
55. ATP channel activation reduces anoxic injury by restoring mitochondrial membrane potential. Am. J. Physiol. Heart Circ. Physiol. 281, H1295-H1303.
56. Bradford, M. M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
57. 2+-ATPase. Biochem. Biophys. Res. Commun. 205, 161-167.
58. 2+-pumping in sarcoplasmic reticulum. In Vanadium in the Environment, Part 1: Chemistry and Biochemistry (Nriagu, J. O., Ed.) pp 333-357, John Wiley & Sons, Inc., New York.
59. Lascano, E. F., Gomez, R. M., and Berria, M. I. (1988) A controlled silver impregnation method to characterize cultured cardiomyocytes. Stain Technol. 63, 221-227.
60. Takada, Y., Hashimoto, M., Kasahara, J., Aihara, K., and Fukunaga, K. (2004) Cytoprotective effect of sodium orthovanadate on ischaemia/reperfusion - induced injury in the rat heart involves AkT activation and inhibition of fodrin breakdown and apoptosis. J. Pharmacol. Exp. Ther. 311, 1249-1255.
61. Aon, M. A., Cortassa, S., Marban, E., and O'Rourke, B. (2003) Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J. Biol. Chem. 278, 44735-44744.
62. Swift, L. M., and Sarvazyan, N. (2001) Localization of dichlorofluorescin in cardiac myocytes: Implications for assessment of oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 278, H982-H990.
63. ATP channel activation. Cardiovasc. Res. 72, 313-321.
64. Soares, S. S., Gutiérrez-Merino, C., and Aureliano, M. (2007) Mitochondria as a target for decavanadate toxicity in Sparus aurata heart. Aquat. Toxicol. 83, 1-9.
65. Chance, B., Sies, H., and Boveris, A. (1979) Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527-605.
66. 2+ in rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 288, H1820-H1828.
67. Stern, A., Yin, X., Tsang, S. S., Davison, A., and Moon, J. (1993) Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem. Cell Biol. 71, 103-112.
68. Colin, M., Madoulet, C., Baccard, N., Arsac, F., and Jardillier, J. C. (1994) Study of sodium orthovanadate as a reverser of multidrug resistance on lymphoblastic leukaemic CEM/VLB100 cells. Anticancer Res. 14, 2383-2388.
69. Cruz, T. F., Morgan, A., and Min, W. (1995) In vitro and in vivo antineoplastic effects of orthovanadate. Mol. Cell. Biochem. 153, 161-166.
70. 2+-pumping ATPase of heart sarcolemma. Characterization, calmodulin dependence, and partial purification. J. Biol. Chem. 256, 3263-3270.
71. Sandirasegarane, L., and Gopalakrishnan, V. (1995) Vanadate increases cytosolic free calcium in rat aortic smooth muscle cells. Life Sci. 56, PL169-PL174.
72. Braunwald, E. (1994) Vanadate increases cytosolic free calcium in rat aortic smooth muscle cells. Cardioscience 5, 139-144.
73. Carmignani, M., Volpe, A. R., Masci, O., Boscolo, P., Di Giacomo, F., Grilli, A., Del Rosso, G., and Felaco, M. (1996) Vanadate as a factor of cardiovascular regulation by interactions with the catecholamine and nitric oxide systems. Biol. Trace Elem. Res. 51, 1-12.
74. Nechay, B. R., Nanninga, L. B., and Nechay, P. S. (1986) Vanadate as a factor of cardiovascular regulation by interactions with the catecholamine and nitric oxide systems. Arch. Biochem. Biophys. 251, 128-138.
75. Willenbucher, R. F., Xie, Y. N., and Eysselein, V. E., Jr. (1992) Mechanisms of camp-mediated relaxation of distal circular muscle in rabbit colon. Am. J. Physiol. 262, G159-G164.
76. Mackenzie, L. H., Roderick, L., Berridge, M. J., Conway, S. T., and Bootman, M. D. (2004) The spatial pattern of atrial cardiomyocytes calcium signalling modulates contraction. J. Cell. Sci. 117, 6327-6337.
77. Zorov, D. B., Juhaszova, M., and Sollott, S. J. (2006) Mitochondrial ROS-induced ROS release: An update and review. Biochim. Biophys. Acta 1757, 509-517.
78. Boveris, A., and Cadenas, E. (1975) Mitochondrial production of superoxide anions and its relationship to the antimycin insensitive respiration. FEBS Lett. 54, 311-314.
79. ATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation. Br. J. Pharmacol. 134, 535-542.
80. Ganote, C. E., and Armstrong, S. C. (2003) Effects of CCCP-induced mitochondrial uncoupling and cyclosporin A on cell volume, cell injury and preconditioning protection of isolated rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 35, 749-759.
81. Lim, D. C., Zuppinger, C., Guo, X., Kuster, G. M., Helmes, M., Eppenberger, H. M., Suter, T. M., Liao, R., and Sawyer, D. B. (2004) Antracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes. J. Biol. Chem. 279, 8290-8299.
82. Nechay, B. R. (1984) Mechanisms of action of vanadium. Annu. Rev. Pharmacol. Toxicol. 24, 501-524.
83. 2+ release. Am. J. Physiol. Cell Physiol. 286, 1139-1151.
84. Poindexter, B. J., Smith, J. R., Buja, L. M., and Bick, R. J. (2001) Calcium signalling mechanisms in dedifferentiated cardiac myocytes: Comparison with neonatal and adult cardiomyocytes. Cell Calcium 30, 373-382.